BRAIN Biotech AG (LON:0RFI)

Market Cap	44.06M
Revenue (ttm)	46.16M
Net Income (ttm)	-10.35M
Shares Out	n/a
EPS (ttm)	-0.47
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9
Average Volume	1,937
Open	2.290
Previous Close	2.330
Day's Range	2.290 - 2.290
52-Week Range	1.214 - 3.705
Beta	n/a
RSI	34.59
Earnings Date	May 28, 2025

About BRAIN Biotech AG

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates through three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was forme...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1993
• Employees: 318
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RFI

Financial Performance

In 2024, BRAIN Biotech AG's revenue was 55.50 million, a decrease of -1.29% compared to the previous year's 56.23 million. Losses were -11.13 million, 34.4% more than in 2023.

Financial numbers in EUR